Cargando…
Subpathway Analysis of Transcriptome Profiles Reveals New Molecular Mechanisms of Acquired Chemotherapy Resistance in Breast Cancer
SIMPLE SUMMARY: The use of diverse omics platforms and small sample sizes in current studies of cancer chemoresistance limits consensus regarding the molecular mechanisms underlying chemoresistance and the applicability of those study findings. We built transcriptome data for chemotherapy-resistant...
Autores principales: | Huo, Yang, Shao, Shuai, Liu, Enze, Li, Jin, Tian, Zhen, Wu, Xue, Zhang, Shijun, Stover, Daniel, Wu, Huanmei, Cheng, Lijun, Li, Lang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563670/ https://www.ncbi.nlm.nih.gov/pubmed/36230801 http://dx.doi.org/10.3390/cancers14194878 |
Ejemplares similares
-
Inference of Subpathway Activity Profiles Reveals Metabolism Abnormal Subpathway Regions in Glioblastoma Multiforme
por: Han, Xudong, et al.
Publicado: (2020) -
Essentiality and Transcriptome-Enriched Pathway Scores Predict Drug-Combination Synergy
por: Li, Jin, et al.
Publicado: (2020) -
DSCN: Double-target selection guided by CRISPR screening and network
por: Liu, Enze, et al.
Publicado: (2022) -
LncSubpathway: a novel approach for identifying dysfunctional subpathways associated with risk lncRNAs by integrating lncRNA and mRNA expression profiles and pathway topologies
por: Xu, Yanjun, et al.
Publicado: (2017) -
Subpathway-LNCE: Identify dysfunctional subpathways competitively regulated by lncRNAs through integrating lncRNA-mRNA expression profile and pathway topologies
por: Shi, Xinrui, et al.
Publicado: (2016)